Rare diseases
Investigational molecules
Locations
Johannes-Lange-Strasse 20, 39319 Jerichow, Germany
Berufsausübungsgemeinschaft Dr. Jörg Schulze in Jerichow, Germany specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Obesity, Overweight, and other specialisations. This site conducts important research.
The medical center is at the forefront of gastroenterology, focusing on innovative treatments for digestive disorders. The center's research is particularly concentrated on conditions like Irritable Bowel Syndrome (IBS), where it explores novel therapeutic approaches to improve patient outcomes.
By investigating the efficacy of treatments such as Symbioflor®2, the center contributes significantly to the understanding and management of IBS, enhancing the quality of life for patients worldwide.
Clinical trials currently enrolling participants at this site.
A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients
GermanyStudy of icotrokinra for adults with moderately to severely active Crohn's disease
GermanyTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
GermanyComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyStudy on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
GermanyEffect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
GermanyStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
